Chris Storgard
Chief Tech/Sci/R&D Officer at HERON THERAPEUTICS, INC.
Profile
Chris M.
Storgard is currently the Chief Medical Officer at Heron Therapeutics, Inc. He previously served as the Vice President-Clinical Research & Development at Ardea Biosciences, Inc. from 2013 to 2016 and as the Chief Medical Officer at Fate Therapeutics, Inc. from 2016 to 2018.
Prior to that, he was a Member & Assistant Professor at Mayo Medical School from 2001 to 2004.
Dr. Storgard holds a doctorate degree from the University of Saskatchewan.
Chris Storgard active positions
| Companies | Position | Start |
|---|---|---|
| HERON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-10-31 |
Former positions of Chris Storgard
| Companies | Position | End |
|---|---|---|
| FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-11-04 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Chief Tech/Sci/R&D Officer | 2016-01-01 |
| Mayo Medical School | Corporate Officer/Principal | 2004-01-01 |
Training of Chris Storgard
| University of Saskatchewan | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
- Stock Market
- Insiders
- Chris Storgard
